021-51111890
购物车（）
sales@molnova.cn
PTP1B-IN-4
CAS No. 765317-72-4
PTP1B-IN-4 ( FRJ; NUN17724; NUN-17724; NUN 17724; PTP1B inhibitor 4; PTP1B-inhibitor-4; )
产品货号. M27767 CAS No. 765317-72-4
PTP1B-IN-4 is an allosteric PTP1B inhibitor with an IC50 of 8 μM. PTP1B-IN-4 can be used in studies about obesity and diabetes.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ￥8068 | 有现货 |
|
| 100MG | ￥14094 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PTP1B-IN-4
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述PTP1B-IN-4 is an allosteric PTP1B inhibitor with an IC50 of 8 μM. PTP1B-IN-4 can be used in studies about obesity and diabetes.
-
产品描述PTP1B-IN-4 is an allosteric PTP1B inhibitor with an IC50 of 8 μM. PTP1B-IN-4 can be used in studies about obesity and diabetes.(In Vitro):In CHO cells overexpressing human IR, PTP1B-IN-4 (250 μM) stimulates the phosphorylation of insulin receptors. PTP1B-IN-4 induces phosphorylation of IRS-1 and Akt which are proteins downstream of the insulin receptor.
-
同义词FRJ; NUN17724; NUN-17724; NUN 17724; PTP1B inhibitor 4; PTP1B-inhibitor-4;
-
通路Metabolic Enzyme/Protease
-
靶点Phosphatase
-
受体FAK
-
研究领域——
-
适应症——
化学信息
-
CAS Number765317-72-4
-
分子量741.5
-
分子式C26H19Br2N3O7S3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCc1oc2cc(ccc2c1C(=O)c1cc(Br)c(O)c(Br)c1)S(O)(=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yang XH, Xiang L, Li X, Zhao TT, Zhang H, Zhou WP, Wang XM, Gong HB, Zhu HL. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents. Bioorg Med Chem. 2012 May 1;20(9):2789-95.
产品手册
关联产品
-
Cyclosporin A
Cyclosporin A is an immunosuppressive agent, binds to the cyclophilin and then inhibits calcineurin with IC50 of 7 nM, widely used in organ transplantation to prevent rejection.
-
NSC 95397
NSC 95397 is a ?potent inhibitor of Cdc25 dual specificity phosphatase(Ki of 32 96 and 40 nM for Cdc25A Cdc25B and Cdc25C respectively).
-
MP07-66
MP07-66 is a novel FTY720-analog devoid of immunosuppressive effects leads to the reactivation of PP2A, which in turn triggers apoptosis of CLL cells.
